Screen Drug Test Opiates

Instructions for use for each test combination of the following drugs: amphetamine, benzodiazepine , cocaine, marijuana, methyldioxymethamphetamine, ketamine, opiates, synthetic marijuana k2/spice.
Single-phase test for the qualitative simultaneous determination of drugs and their metabolites in human urine.

Precautions
Product not intended for medical or diagnostic use.
Do not use beyond the expiration date.
Store the test strip panel in the closed pouch until needed.
All samples must be considered potentially dangerous and therefore must be handled with the precautions for use relating to potentially infectious products.
After use, the panel must be disposed of according to the local regulations in force.
Store in the closed container at a temperature between 2° and 30°C.
The test strip panel is stable until the expiry date indicated on the package label.
The test strip panel should be stored in the closed pouch until needed.
Do not freeze.
Do not use beyond the expiry date.

Intended use and summary
Screening test for the simultaneous detection of several drugs.
The rapidity and sensitivity of immunological tests have led them to be considered the most accepted as urine screening tests for the simultaneous detection of drugs of abuse.
The one-step test strip brush (Urine) is a rapid lateral flow immunochromatographic test for the qualitative determination of the following drugs without the aid of instruments:

Test	Calibrator	Cut-off (ng/ml)< /b>
Cocaine (COC) Amphetamine (AMP) Methyldioxymethamphetamine (MDMA) Marijuana (THC) Opiates (OPI) Benzodiazepine (BZO) Ketamine (KET) Synthetic marijuana k2/spice	benzolechnogine D-amphetamine D,L-methyldioxymethamphetamine 11 -nor-Δ9-THC-9 COOH morphine Oxazepam Ketamine jwh-018 and jwh-073	300 1,000 500 50 2,000 300 1,000 50

This test provides data only preliminary analytics.
More chemical methods specifications must be used as confirmation of the analytical result.
Gas chromatography and mass spectrometry (GC/MS) are considered preferential confirmation methods.
Each result for the determination of the presence of drugs of abuse must be correlated to clinical considerations and professional judgment, particularly when the preliminary result is of positivity.
a rapid urine screening test that does not require the use of special instruments.
The test uses antibodies to selectively detect high levels of specific substances in human urine.

Residence times are approximate for each substance as they vary based on frequency of use, mass body, age, state of health, tolerance to narcotic substances and urine pH.
The product detects the presence of narcotic substances in the urine only after their metabolisation.

COCAINE (COC)
Cocaine is a powerful central nervous system stimulant as well as local anesthetic derived from the coca plant.
The substance is often self-administered via inhalation or intravenous injection or by smoking the base substance.

AMPHETAMINE (AMP)
Amphetamine is a a substance also used for therapeutic purposes.
The substance is often self-administered via inhalation or ingestion.
High doses produce enhanced stimulation of the central nervous system and induce euphoria, alertness, reduced appetite, a sense of greater energy and strength.
More reactions Acute symptoms produce anxiety, paranoia, hallucinations and psychotic behavior.

METHYLDIOXYMETHAMPHETAMINE (MDMA)
Ecstasy is not a stimulant, even if it has in common with amphetamines the ability to to increase blood pressure and heart rate.
Produces some changes in perception such as greater sensitivity to in the light, difficulty of focus, blurred vision.
The effect that occurs in practically all those who take this substance is is to make the jaw clench.

MARIJUANA (THC)
Tetrahydrocannabinol is a the active ingredient of cannabis.
When is Smoked or taken orally, THC produces euphoria. Regular users have short-term memory impairment and learning delays, and may also have transient episodes of confusion and anxiety.
Consumption in the long term ends relatively heavy can be associated with behavioral disorders.

OPIOIDS (OPI)
The class of opiates refers to any substance derived from the opium poppy, including natural compounds such as morphine, codeine and semi-synthetic substances such as heroin.
Opiates act on pain control by depressing the central nervous system.
Withdrawal symptoms may include sweating, tremors, nausea and irritability.
Opiates can be taken orally or by intravenous, intramuscular and subcutaneous injection.
Consumers can also take the substance intravenously or through inhalation.

BENZODIAZEPINE (BZO)
These are drugs frequently prescribed for the symptomatic treatment of anxiety, of sleep disorders, epileptic seizures and alcohol withdrawal syndrome.
Sudden discontinuation may cause induce symptoms such as sleep disturbances, gastrointestinal disturbances, loss of appetite, sweating, tremor, weakness, anxiety and changes in perception.

KETAMINE (KET)
Ketamine is a a dissociative anesthetic for human and veterinary use.
marketed in Italy under the names Ketalar, Ketanest and Ketaset and in the human field it is classified as Drug "H" and should be used exclusively in a hospital environment by an anesthetist-resuscitator.
Like all neuro and psycholactic drugs, it can be abuse and recreational use, prohibited and sanctioned by law, as a narcotic substance.

SYNTHETIC MARIJUANA K2/SPICE (K2/SPICE)
Synthetic Marijuana or K2 is a psychoactive herb and chemical that when consumed mimics the effects of Marijuana.
Best known by the trade names K2 and Spice, both widely used to refer to any synthetic Marijuana product.

< b>Principle
The one-step test strip panel (Urine) is a rapid immunochromatographic test based on the principle of competitive binding.
Drugs that may be present in the urine sample compete with the relevant conjugate for the same antibody binding sites.
During the test, a urine sample migrates by capillary action. along the membrane.
A drug, if present in the urine sample, at a concentration lower than its cut-off, will not be capable of saturating all the binding sites of the particles bound to the relevant antibodies present in the strip.
Antibody-bound particles will be captured by the immobilized conjugate and a visible colored band will appear. in the test band area of the relevant strip.
The colored band will not form. in the relevant area if the drug level will be above your cut-off, as all relevant antibody binding sites will be saturated.
A urine sample positive for the test drug will not cause the formation of the colored band due to drug competition, while a urine sample negative for the drug being tested or a sample containing a drug concentration lower than the cut-off will cause the formation of the colored band in the specific test area.
As a control of the procedure, the following will appear: a colored band in the relevant area, indicating that it is a quantity has been used correct sample size and that migration on the membrane is occurred.

Reagents
Each strip in the panel contains mouse monoclonal antibodies bound to the particles and the corresponding.
The panel of one-step test strips (Urine) is a rapid conjugate lateral flow immunochromatographic assay for each drug.
Goat antibodies are used for the control band.

Sample collection and preparation
Collect the urine sample in a clean, dry container.
Urine samples collected at any time of the day can be used.
Urine samples with evident presence of precipitate must be centrifuged, filtered or allowed to settle in order to obtain a clear sample on which to carry out the test.
Urine samples can be stored at a temperature of 2-8°C for a maximum of 48 hours.
For prolonged storage, it is It is possible to freeze the samples and store them at a temperature below -20°C.
Before using frozen samples it is It is necessary to thaw them and mix them carefully.

Procedure for use
1. Before opening the package, bring it to room temperature. Remove the product from the packaging and use it as soon as possible.
2. Uncap the strips. Immerse the product vertically, in the direction of the arrows, in the urine sample for at least 10/15 seconds. Immerse the product up to the level of the wavy lines on the strips but not above them.
3. Replace the cap on the device and place the product horizontally on a flat, non-absorbent surface. Read the result after 5 minutes. Do not interpret the result after 10 minutes.

Interpretation of results
Negative*: a colored band appears in the control area (C) and a second in the test zone (T) for each drug indicating a negative result.
The negative result indicates that the concentration of the drug in question in the urine is below the detectable cut-off level for that specific drug.
*the shade of color in the test zone (T) can vary, but must be considered negative whenever a faint colored band appears.
Positive: a colored band appears in the control zone (C) but not in the test zone (T ) for each drug indicating a positive result.
The positive result indicates that the concentration of the drug in question in the urine is higher than the detectable cut-off level for that specific drug.
Invalid: the control band (C) does not appear.
The most common causes Plausible causes for the failure of the control band to appear may be an insufficient sample volume or incorrect analytical procedure.
Recheck the procedure and repeat the test using a new panel.
If the problem persists, immediately stop using the kit and contact your local distributor.
If the test is positive, avoid aggressive behavior and calmly seek dialogue with the person concerned.
Get advice from your doctor, a psychologist or contact the competent service for your area.

Quality control
The test includes an internal control system consisting of the red band that appears in the control area (C).
The appearance of this band confirms that the test is successful. performed correctly with sufficient sample volume, that membrane absorption is adequate result and correct procedure.
Standard controls are not provided with the kit; in any case, it is recommended to test positive and negative controls, as good laboratory practice, to confirm the test procedure and verify its correct characteristics.

Limitations
1. The One-step test strip panel (Urine) provides only a qualitative preliminary analytical result. &` It is necessary to adopt a second analytical method. Gas chromatography and mass spectrometry (GC/MS) are considered preferred confirmation methods if the test is positive.
2. It is possible that technical or procedural errors, as well as as interfering substances present in the urine sample can cause erroneous results.
3. It is possible that adulterants such as bleach and/or alum present in the urine sample may cause erroneous results regardless of the analytical method used. If the presence of such substances is suspected, the test must be repeated with another urine sample.
4. A positive result indicates the presence of the drug or its metabolites but not the level of intoxication or the route of administration or the concentration in the urine.
5. A negative result does not necessarily mean that the urine sample is drug-free. A negative result can be get when the drug is present but at a concentration lower than the test cut-off level.
6. The test is not able to distinguish between the drug and a medicine containing the same substance false positives may be caused by some medicines.

Format
• 1 urine container.
• 1 Drug Test Cocaine.
• information leaflet.